Literature DB >> 24475402

Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues.

Azar Baradaran1.   

Abstract

Entities:  

Keywords:  Diabetic nephropathy; Lipoprotein(a); Renal failure

Year:  2012        PMID： 24475402      PMCID： PMC3886158          DOI： 10.5812/nephropathol.8107

Source DB:  PubMed          Journal:  J Nephropathol        ISSN： 2251-8363


× No keyword cloud information.
  19 in total

1.  Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Elisabetta Baffero; Adriana Garzaniti; Gabriele Pelissero; Silvia Collaviti; Annalisa Grugnetti; Pietro Gallotti; Arturo Pujia; Sebastiano B Solerte; Andrea Giustina
Journal:  Endocrine       Date:  2011-10-11       Impact factor: 3.633

2.  Lipoprotein(a) levels in type II diabetic patients are not influenced by metabolic control or by microalbuminuria.

Authors:  S Zambon; G Baldo-Enzi; M Baiocchi; R Nosadini; E Manzato; G Crepaldi
Journal:  Diabetes Care       Date:  1994-12       Impact factor: 19.112

3.  Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.

Authors:  Jacqueline Suk Danik; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

4.  Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes.

Authors:  Manouchehr Nakhjavani; Afsaneh Morteza; Alireza Esteghamati; Omid Khalilzadeh; Ali Zandieh; Reza Safari
Journal:  Lipids       Date:  2010-12-14       Impact factor: 1.880

5.  Lipoprotein(a) induces glomerular superoxide anion production.

Authors:  S Greiber; M Kreusel; H Pavenstädt; P Schollmeyer; C Wanner
Journal:  Nephrol Dial Transplant       Date:  1997-07       Impact factor: 5.992

6.  Association of serum lipoprotein(a) with ultrasonographically determined early atherosclerotic changes in the carotid and femoral arteries in kidney transplanted patients.

Authors:  H Nasri; A Baradaran
Journal:  Transplant Proc       Date:  2004-11       Impact factor: 1.066

7.  Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM.

Authors:  G Velho; D Erlich; E Turpin; D Néel; D Cohen; P Froguel; P Passa
Journal:  Diabetes Care       Date:  1993-05       Impact factor: 19.112

8.  Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients.

Authors:  Hamid Nasri; Azar Baradaran
Journal:  Saudi J Kidney Dis Transpl       Date:  2005 Apr-Jun

9.  Effect of glycation on the properties of lipoprotein(a).

Authors:  K Makino; J W Furbee; A M Scanu; G M Fless
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-03       Impact factor: 8.311

10.  Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.

Authors:  H Kapelrud; H J Bangstad; K Dahl-Jørgensen; K Berg; K F Hanssen
Journal:  BMJ       Date:  1991-09-21
View more
  26 in total

1.  Effect of aqueous extract of Vernonia amygdalina on atherosclerosis in rabbits.

Authors:  Omotola Abdulmalik; Olulola Olutoyin Oladapo; Modupeola Oluwabunmi Bolaji
Journal:  ARYA Atheroscler       Date:  2016-01

2.  Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes.

Authors:  Siwei Zhang; Huali Xu; Xiaofeng Yu; Yi Wu; Dayun Sui
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

3.  NORMAL FEMORAL ARTERY INTIMA-MEDIA THICKNESS AMONG HEALTHY NIGERIAN ADULTS; RELATIONSHIP WITH AGE, GENDER AND BODY MASS INDEX.

Authors:  M A Soneye; A J Adekanmi
Journal:  J West Afr Coll Surg       Date:  2018 Oct-Dec

4.  Medicinal Plants and New Concerns in Statin Consumption.

Authors:  Hamid Nasri; Mahmoud Rafieian-Kopaei
Journal:  Iran J Public Health       Date:  2013-09       Impact factor: 1.429

5.  The contribution of syndemic conditions to cardiovascular disease risk.

Authors:  Violeta J Rodriguez; Antonio Chahine; Manasi S Parrish; Maria L Alcaide; Tae Kyoung Lee; Barry Hurwitz; Manisha Sawhney; Stephen M Weiss; Deborah L Jones; Mahendra Kumar
Journal:  AIDS Care       Date:  2020-05-13

6.  Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial.

Authors:  Azar Baradaran
Journal:  Daru       Date:  2013-03-08       Impact factor: 3.117

7.  Renoprotective effects of metformin.

Authors:  Running Hamid Nasri
Journal:  Daru       Date:  2013-05-16       Impact factor: 3.117

8.  Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?

Authors:  Hamid Nasri
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

9.  Suppressive impact of anethum graveolens consumption on biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits.

Authors:  Mahbubeh Setorki; Mahmoud Rafieian-Kopaei; Alireza Merikhi; Esfandiar Heidarian; Najmeh Shahinfard; Roya Ansari; Hamid Nasri; Nafiseh Esmael; Azar Baradaran
Journal:  Int J Prev Med       Date:  2013-08

10.  Comment on: The Protective Role of Silymarin and Deferoxamine Against Iron Dextran-Induced Renal Iron Deposition in Male Rats.

Authors:  Azar Baradaran
Journal:  Int J Prev Med       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.